Skip to main content

Table 2 Different steps of analysis and sample size

From: Limiting treatment and shortening of life: data from a cross-sectional survey in Germany on frequencies, determinants and patients’ involvement

(1) Analysis of the whole sample regarding the frequency of limiting treatment as one aspect of end-of-life practices (n = 403)

(2) Analysis of the subgroup concerning “Types of limited treatment and expected consequences” (n = 104)

(3) Analysis of the subgroup “Decision-making and patient involvement” (n = 81)

(4) Regression analysis on determinants associated with limitation of treatment and expected shortening of life (n = 403)